NCT00025116View on ClinicalTrials.gov

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 24, 2001

Primary Completion Date

June 5, 2003

Study Completion Date

September 22, 2008

Conditions
Prostate Cancer
Interventions
DRUG

gefitinib

Trial Locations (2)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

M4X 1K9

Ontario Cancer Institute, Toronto

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK